Form 8-K - Current report:
SEC Accession No. 0000950170-25-091820
Filing Date
2025-07-01
Accepted
2025-06-30 20:00:38
Documents
13
Period of Report
2025-06-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kant-20250630.htm   iXBRL 8-K 78028
2 EX-3.1 kant-ex3_1.htm EX-3.1 6442
3 EX-3.2 kant-ex3_2.htm EX-3.2 81083
4 EX-99.1 kant-ex99_1.htm EX-99.1 26013
  Complete submission text file 0000950170-25-091820.txt   329281

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kant-20250630.xsd EX-101.SCH 31897
16 EXTRACTED XBRL INSTANCE DOCUMENT kant-20250630_htm.xml XML 4716
Mailing Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040
Business Address 7683 SE 27TH STREET SUITE 481 MERCER ISLAND WA 98040 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 251093806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)